Literature DB >> 17766194

Vitamin A intake and elevated serum retinol levels in children and young adults with cystic fibrosis.

Asim Maqbool1, Rose C Graham-Maar, Joan I Schall, Babette S Zemel, Virginia A Stallings.   

Abstract

BACKGROUND: Individuals with cystic fibrosis (CF) and pancreatic insufficiency (PI) are at risk for fat-soluble vitamin deficiency, including vitamin A. Recent evidence suggests current practices of vitamin A intake results in elevated serum retinol.
METHODS: Serum retinol was assessed in 78 subjects (8 to 25 years old) with CF and PI by high performance liquid chromatography, and compared to the U.S. National Health and Nutrition Examination Survey (NHANES) data of subjects of similar age and gender. Vitamin A intake, anthropometry and FEV(1) were measured, and their relationship to serum retinol status was assessed.
RESULTS: Median (range) serum retinol was 80 microg/dL (33 to 208) in subjects with CF; 58% were above the NHANES reference range (30 to 72 microg/dL). Total vitamin A intake from diet and supplements was high (608+431% Recommended Dietary Allowance). Serum retinol was not correlated with vitamin A intake, age or gender, and was inversely correlated with weight and height z scores (r=-0.28, p<0.05) in the subjects with CF.
CONCLUSIONS: Both vitamin A intake and serum retinol were elevated in subjects with CF and PI, corroborating recent evidence of elevated serum retinol in preadolescent children with CF. These findings indicate the need for further study of dosing and monitoring care practices of vitamin A, to ensure adequacy and to avoid toxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17766194      PMCID: PMC4447209          DOI: 10.1016/j.jcf.2007.07.002

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  15 in total

Review 1.  Consensus report on nutrition for pediatric patients with cystic fibrosis.

Authors:  Drucy Borowitz; Robert D Baker; Virginia Stallings
Journal:  J Pediatr Gastroenterol Nutr       Date:  2002-09       Impact factor: 2.839

2.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

3.  ATS statement--Snowbird workshop on standardization of spirometry.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1979-05

4.  Elevated vitamin A intake and serum retinol in preadolescent children with cystic fibrosis.

Authors:  Rose C Graham-Maar; Joan I Schall; Nicolas Stettler; Babette S Zemel; Virginia A Stallings
Journal:  Am J Clin Nutr       Date:  2006-07       Impact factor: 7.045

5.  CDC growth charts: United States.

Authors:  R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson
Journal:  Adv Data       Date:  2000-06-08

6.  Water-miscible, emulsified, and solid forms of retinol supplements are more toxic than oil-based preparations.

Authors:  Anne M Myhre; Monica H Carlsen; Siv K Bøhn; Heidi L Wold; Petter Laake; Rune Blomhoff
Journal:  Am J Clin Nutr       Date:  2003-12       Impact factor: 7.045

7.  Hypervitaminosis A unmasked by acute viral hepatitis.

Authors:  D E Hatoff; S L Gertler; K Miyai; B A Parker; J B Weiss
Journal:  Gastroenterology       Date:  1982-01       Impact factor: 22.682

8.  Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture.

Authors:  H Melhus; K Michaëlsson; A Kindmark; R Bergström; L Holmberg; H Mallmin; A Wolk; S Ljunghall
Journal:  Ann Intern Med       Date:  1998-11-15       Impact factor: 25.391

9.  Serum retinol levels and the risk of fracture.

Authors:  Karl Michaëlsson; Hans Lithell; Bengt Vessby; Håkan Melhus
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

10.  Some biochemical indices of nutrition in treated cystic fibrosis patients.

Authors:  N W Solomons; J B Wagonfeld; C Rieger; R A Jacob; M Bolt; J V Horst; R Rothberg; H Sandstead
Journal:  Am J Clin Nutr       Date:  1981-04       Impact factor: 7.045

View more
  9 in total

1.  Why bother to take vitamins?

Authors:  Alison Morton
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

Review 2.  Endocrine Disorders in Cystic Fibrosis.

Authors:  Scott M Blackman; Vin Tangpricha
Journal:  Pediatr Clin North Am       Date:  2016-08       Impact factor: 3.278

3.  Relationship Between Fat-Soluble Vitamin Supplementation and Blood Concentrations in Adolescent and Adult Patients With Cystic Fibrosis.

Authors:  Oranan Siwamogsatham; Wei Dong; Jose N Binongo; Ritam Chowdhury; Jessica A Alvarez; Shawna J Feinman; Jessica Enders; Vin Tangpricha
Journal:  Nutr Clin Pract       Date:  2014-04-17       Impact factor: 3.080

4.  Fat-soluble vitamins in cystic fibrosis and pancreatic insufficiency: efficacy of a nutrition intervention.

Authors:  Chiara Bertolaso; Veronique Groleau; Joan I Schall; Asim Maqbool; Maria Mascarenhas; Norma E Latham; Kelly A Dougherty; Virginia A Stallings
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-04       Impact factor: 2.839

5.  CYP26C1 Is a Hydroxylase of Multiple Active Retinoids and Interacts with Cellular Retinoic Acid Binding Proteins.

Authors:  Guo Zhong; David Ortiz; Alex Zelter; Abhinav Nath; Nina Isoherranen
Journal:  Mol Pharmacol       Date:  2018-02-23       Impact factor: 4.436

6.  Vitamin A and beta (β)-carotene supplementation for cystic fibrosis.

Authors:  Jorrit Jv de Vries; Anne B Chang; Catherine M Bonifant; Elizabeth Shevill; Julie M Marchant
Journal:  Cochrane Database Syst Rev       Date:  2018-08-09

7.  The Association and Mediating Biomarkers of Serum Retinol in Influencing the Development of Type 2 Diabetes: A Prospective Cohort Study in Middle-Aged and Elderly Population.

Authors:  Xiuyu Pang; Sen Yang; Xiaoyu Guo; Hongyin Li; Yingfeng Zhang; Chunbo Wei; Yu Wang; Changhao Sun; Ying Li
Journal:  Front Nutr       Date:  2022-03-29

Review 8.  Update on the management of vitamins and minerals in cystic fibrosis.

Authors:  Senthilkumar Sankararaman; Sara J Hendrix; Terri Schindler
Journal:  Nutr Clin Pract       Date:  2022-08-23       Impact factor: 3.204

9.  CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis.

Authors:  Olaf Sommerburg; Susanne Hämmerling; S Philipp Schneider; Jürgen Okun; Claus-Dieter Langhans; Patricia Leutz-Schmidt; Mark O Wielpütz; Werner Siems; Simon Y Gräber; Marcus A Mall; Mirjam Stahl
Journal:  Antioxidants (Basel)       Date:  2021-03-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.